By Robert Weisman, Globe StaffThe chief executive of Millennium Pharmaceuticals in Cambridge resigned suddenly Thursday after its Japanese parent company, Takeda Pharmaceutical Co., moved to fold Millennium’s big Cambridge-based cancer research unit into ...
[Published Boston Globe - May 10 2013]